Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FERMT2 | Q96AC1 | 4/20 | 0.56 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.49 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PRNP | P04156 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL902310 | 0.96 | FERMT2 (0.56) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL4365534 | 0.91 | FERMT2 (0.55) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL5275609 | 0.84 | NR4A2 (0.56) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL4374933 | 0.83 | NR4A2 (0.46) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL4374938 | 0.82 | CCR1 (0.49) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL6661654 | 0.82 | NR4A2 (0.50) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL29625389 | 0.82 | NR4A2 (0.50) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL4374931 | 0.81 | FERMT2 (0.52) | FERMT2NR4A2SOS2CYP1A2CCR1 | |
| SCHEMBL8909568 | 0.80 | ADRB2 (0.41) | FERMT2 | |
| SCHEMBL8907641 | 0.80 | LOXL2 (0.49) | FERMT2CYP1A2TDP1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7307276-B2 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2007-12-11 | — | — | US | claimed |
| US-7056600-B2 | Layer configuration comprising an electron-blocking element | AGFA GEVAERT (BE) | 2006-06-06 | — | — | US | claimed |
| US-6977390-B2 | Layer configuration comprising an electron-blocking element | AGFA GEVAERT (BE) | 2005-12-20 | — | — | US | claimed |
| US-20040040594-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | US | claimed |
| US-20040044214-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | US | claimed |
| US-20040036067-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-02-26 | — | — | US | claimed |
| US-9458376-B2 | Electrochromic iptycenes | POLISHAK BRENT M (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160137914-A1 | ELECTROCHROMIC IPTYCENES | POLISHAK BRENT M (US) | 2016-05-19 | — | — | US | disclosed |
| WO-2009148659-A2 | ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2009-12-10 | — | — | WO | disclosed |
| US-20090266991-A1 | METHOD OF AUTHENTICATING TAGGED POLYMERS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-10-29 | — | — | US | disclosed |
| EP-1820193-B1 | METHOD OF AUTHENTICATING TAGGED POLYMERS | SABIC INNOVATIVE PLASTICS IP (NL) | 2009-04-22 | — | — | EP | disclosed |
| US-7307276-B2 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2007-12-11 | — | — | US | disclosed |
| US-7307276-B2 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2007-12-11 | — | — | US | disclosed |
| WO-2004019347-A1 | LAYER CONFIGURATION COMPRISING AN ELECTRON-BLOCKING ELEMENT | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | WO | disclosed |
| US-20040036067-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-02-26 | — | — | US | disclosed |
| US-20030189749-A1 | ELECTROCHROMIC-NANOPARTICLE DISPLAYS | E INK CORPORATION (US) | 2003-10-09 | — | — | US | disclosed |
| US-6580545-B2 | Electrochromic-nanoparticle displays | E INK CORPORATION | 2003-06-17 | — | — | US | disclosed |
| WO-2002086611-A1 | ELECTROCHROMIC-NANOPARTICLE DISPLAYS | E INK CORPORATION (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020154382-A1 | Electrochromic-nanoparticle displays | E INK CORPORATION | 2002-10-24 | — | — | US | disclosed |
| WO-1997048705-A1 | POTASSIUM CHANNEL BLOCKERS | UNIVERSITY COLLEGE LONDON (GB) | 1997-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044214-A1 | Layer configuration comprising an electron-blocking element | PCBP1, RER1, SCO2 | FERMT2 2335/4885NR4A2 154/4885SOS2 1272/4885 |
| US-20160137914-A1 | ELECTROCHROMIC IPTYCENES | IDH3A, EYA2, IDH2 | FERMT2 2563/4885NR4A2 2341/4885SOS2 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.